Global respiratory disease testing market is anticipated to register remarkable growth over the coming seven years owing to rising incidence of COPD (chronic obtrusive pulmonary diseases) and other respiratory diseases. In addition, rising geriatric population base and technological advancements in disease testing devices is further expected to fuel the market growth over the forecast period. In 2012, according to a report published by American Lung Associations, COPD was the prime cause of death in the U.S. and is expected to be to the leading respiratory disorder in the coming years.
http://www.grandviewresearch.com/industry-analysis/respiratory-disease-testing-market
No comments:
Post a Comment